黑料吃瓜群网

Epilepsy drugs in womb linked to poor school results


Friday, 30 March, 2018

Epilepsy drugs in womb linked to poor school results

Exposure to epilepsy drugs in the womb is linked to significantly poorer school test results among seven-year-olds, according to new research published online in the聽

Women with epilepsy who need drugs to control their seizures are currently advised to continue taking them during pregnancy because convulsions can harm both mother and unborn child.

Several studies indicate that epilepsy drugs, particularly sodium valproate, taken during pregnancy, are associated with neurodevelopmental disorders, but few of these studies have been based on real-life circumstances (population data).

To try and address this, the researchers used routinely collected healthcare information from the Welsh聽 (SAIL) databank and national school test (key stage 1) data to compare the academic performance of seven-year-olds in Wales born to mothers with epilepsy.

Prescription patterns were divided into categories: treatment with one drug (carbamazepine, lamotrigine or sodium valproate); a combination of several drugs; and no drug treatment.

Twenty (54%) of the 39 mums prescribed several drugs were taking sodium valproate, but there were 15 different drug combinations in all.

The results showed that children born to mums who had been prescribed carbamazepine or lamotrigine, or nothing, performed just as well as those born to mums of the same age and deprivation level, but without epilepsy (comparison group).

But those whose mums had been prescribed sodium valproate during their pregnancy performed 10.5 to just under 13%聽less well on all KSI tests than those in the comparison group.

And children born to mums who had been prescribed a cocktail of epilepsy drugs achieved worse results still. Their scores were 19鈥22%聽lower.

Excluding children with epilepsy and whose mothers smoked from the analysis did not聽materially change the results.

The researchers acknowledge that they weren鈥檛 able to account for certain potentially influential factors, such as the mothers鈥 IQ, weight or alcohol consumption; the doses of epilepsy drugs prescribed; or intake of folic acid around conception.

But their results echo those of other independent studies, they point out.

And they go on to say: 鈥淲hile this study highlights the risk of cognitive effects in the children of mothers prescribed sodium valproate or multiple [anti-epilepsy drugs], it is important to acknowledge that some epilepsies are difficult to treat without these treatment regimens.鈥

And they recommend: 鈥淲omen with epilepsy should be informed of this risk and alternative treatment regimens should be discussed before their pregnancy with a physician that specialises in epilepsy.鈥

In a linked commentary, Dr Richard Chin of the emphasises the importance of a study that is based on population data as this can be used to inform preventative/interventional strategies and help women to better understand the implications of epilepsy treatment while pregnant.

鈥淏y providing 鈥榝unctional鈥 outcome data from their study, the authors have now provided information that prospective parents may find readily tangible: it should be included in information given to women with epilepsy prior to pregnancy,鈥 he advocates.

Image credit: 漏stock.adobe.com/au/Sudok1

Related News

Victoria's Q3 median ED wait times the lowest on record

Victoria's quarter three performance data (January–March) has shown improvement across...

Irregularities in a clinician's cases prompt 15-month lookback

St Vincent's 黑料吃瓜群网 Sydney has detailed a 15-month lookback review — prompted by...

Two researchers receive $899,000 in cardiovascular funding

In heart-related news this Heart Week (5–11 May), two University of Newcastle researchers...



Content from other channels on our network


  • All content Copyright 漏 2025 黑料吃瓜群网-Farrow Pty Ltd